Upfront Management of ALK-Rearranged Metastatic Non-small Cell Lung Cancer: One Inhibitor Fits All?

被引：0
|
作者：
Fabrizio Tabbò
Francesco Passiglia
Silvia Novello
机构：
[1] University of Turin,Department of Oncology
[2] San Luigi Hospital,undefined
来源：
Current Oncology Reports | 2021年 / 23卷
关键词：
ALK; Rearrangements; First-line; NSCLC; TKI; New-generation; Crizotinib; Ceritinib; Alectinib; Brigatinib; Lorlatinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
    Mota, Ines
    Patrucco, Enrico
    Mastini, Cristina
    Mahadevan, Navin R.
    Thai, Tran C.
    Bergaggio, Elisa
    Cheong, Taek-Chin
    Leonardi, Giulia
    Karaca-Atabay, Elif
    Campisi, Marco
    Poggio, Teresa
    Menotti, Matteo
    Ambrogio, Chiara
    Longo, Dario L.
    Klaeger, Susan
    Keshishian, Hasmik
    Sztupinszki, Zsofia M.
    Szallasi, Zoltan
    Keskin, Derin B.
    Duke-Cohan, Jonathan S.
    Reinhold, Bruce
    Carr, Steven A.
    Wu, Catherine J.
    Moynihan, Kelly D.
    Irvine, Darrell J.
    Barbie, David A.
    Reinherz, Ellis L.
    Voena, Claudia
    Awad, Mark M.
    Blasco, Rafael B.
    Chiarle, Roberto
    NATURE CANCER, 2023, 4 (07) : 1016 - +
  • [12] Src mediates acquired resistance to ALK inhibitor in ALK-rearranged non-small cell lung cancers
    Yoshida, Ryohei
    Okumura, Shunsuke
    Sasaki, Takaaki
    Osaki, Yoshinobu
    CANCER RESEARCH, 2016, 76
  • [13] ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
    Ines Mota
    Enrico Patrucco
    Cristina Mastini
    Navin R. Mahadevan
    Tran C. Thai
    Elisa Bergaggio
    Taek-Chin Cheong
    Giulia Leonardi
    Elif Karaca-Atabay
    Marco Campisi
    Teresa Poggio
    Matteo Menotti
    Chiara Ambrogio
    Dario L. Longo
    Susan Klaeger
    Hasmik Keshishian
    Zsófia M. Sztupinszki
    Zoltan Szallasi
    Derin B. Keskin
    Jonathan S. Duke-Cohan
    Bruce Reinhold
    Steven A. Carr
    Catherine J. Wu
    Kelly D. Moynihan
    Darrell J. Irvine
    David A. Barbie
    Ellis L. Reinherz
    Claudia Voena
    Mark M. Awad
    Rafael B. Blasco
    Roberto Chiarle
    Nature Cancer, 2023, 4 : 1016 - 1035
  • [14] Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer
    Califano, Raffaele
    Greystoke, Alastair
    Lal, Rohit
    Thompson, Joyce
    Popat, Sanjay
    LUNG CANCER, 2017, 111 : 51 - 58
  • [15] Concurrent Genomic Alterations in ALK-Rearranged Non-Small Cell Lung Cancer Patients
    Clave, S.
    Salido, M.
    Gibert, J.
    Hardy-Werbin, M.
    Weingartner, E.
    Hernandez, J.
    Nichol, D.
    Rocha, P.
    Riera, X.
    Blanco, R.
    Bosch-Barrera, J.
    Taus, A.
    Pijuan, L.
    Bellosillo, B.
    Arriola, E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S508 - S509
  • [16] Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer Patients
    Miyazaki, Kunihiko
    Sato, Shinya
    Kodama, Takahide
    Numata, Takeshi
    Endo, Takeo
    Yamamoto, Yusuke
    Shimizu, Kei
    Yamada, Hideyasu
    Hayashihara, Kenji
    Okauchi, Shinichiro
    Satoh, Hiroaki
    Yamada, Yutaka
    Tamura, Tomohiro
    Saito, Kazuto
    Kikuchi, Norihiro
    Kurishima, Koichi
    Ishikawa, Hiroichi
    Watanabe, Hiroko
    Shiozawa, Toshihiro
    Hizawa, Nobuyuki
    Funayama, Yasunori
    Hayashi, Shigen
    Nakamura, Hiroyuki
    Yamashita, Takaaki
    IN VIVO, 2020, 34 (04): : 2001 - 2007
  • [17] The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer
    Pan, Yue
    Deng, Chao
    Qiu, Zhenhua
    Cao, Chenghui
    Wu, Fang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [18] Expanding therapies for crizotinib refractory ALK-rearranged non-small cell lung cancer
    Barnes, Tristan A.
    Leighl, Natasha B.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S458 - S461
  • [19] Immune Recognition of ALK Fusion Proteins in Patients with ALK-Rearranged Non-Small Cell Lung Cancer
    Awad, Mark
    Mastini, Cristina
    Patino, Rafael
    Mologni, Luca
    Voena, Claudia
    Mussolin, Lara
    Mach, Stacy
    Adeni, Anika
    Lydon, Christine
    Janne, Pasi
    Chiarle, Roberto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1162 - S1163
  • [20] Ceritinib-a second-generation ALK inhibitor overcoming resistance in ALK-rearranged non-small cell lung cancer
    Rothschild, Sacha I.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (06) : 379 - 381
12345